The Consumer/OTC report is a weekly semi-customized report covering major consumer health companies and global industry events. The report provides updates on financial performance & forecasts, business development, drug delivery, Rx/OTC switches, product launches, and public health issues. The report helps clients to gain additional insights on the market dynamics and to further build their OTC business.

Clients can choose areas of emphasis, including:

• Geographic Focus (key developed, and/or emerging markets)
• Topic breadth (for example, including nutraceuticals, distributors/retailers)
• Competitive Company Set

Global diabetes market has been expanding rapidly, driven by increased prevalence, improved diagnosis rates and new drug & device developments. Pharma companies are looking to expand into emerging countries where swift growth is expected. However, the market is also highly exposed to increased generic entries and competitive pricing pressure.

HealthACE Diabetes is a thrice-weekly intelligence service targeted for professionals in the diabetes/obesity field. This report is a syndicated report covering pharma/biotech companies with focus in diabetes/insulin/obesity. It provide outlooks in both core and emerging markets, business strategies, key products developments and forecasts.

The annual subscription includes following features:

• Tri-weekly reports (Monday, Wednesday, & Friday), which are available to all company key stakeholders
• Email alert featuring key headlines
• PDF attachment of the entire report with additional analyses by HealthACE analysts
• Access to our analyst to provide additional insights

The pharmaceutical supply chain is the ways for which branded, generic, and OTC products are delivered from drug manufacturers to consumers. This complex supply system involves multiple organizations - pharma/biotech/generic companies, wholesale distributors, pharmacies (retail/mail order), and PBMs. These players in the supply chain are constantly evolving, and commercial relationships vary considerably.

Our weekly drug distribution report covers the pharmaceutical supply chain in the U.S. It provides insights on companies' business strategies and expansion, relationships between key players of the supply chain, updates on healthcare information technology and supply chain logistics.

Our target customers are wholesalers and pharmacy managers, looking to understand the competitive dynamics in their highly concentrated industries.

These are client-specific services, typically provided to brand or franchise management, that want rapid reporting on developments in a specific therapeutic class. HealthACE monitors investment analyst and news reports for relevant content.

Typically, we provide alerts on key product, regulatory and competitive developments. Our clients want to anticipate management's call on "what does this mean?", and provide a common competitive information base across their team. Features often include the maintenance of sales forecast and pipeline databases, as well as news monitoring.

Delivery frequency and format is tailored to the client's needs, but often includes an "as needed" rapid report, followed by a weekly summary.